FORM 8.1(a) & (b) - Mural Oncology plc

Seeking Alpha / 1 hour ago 2 Views

Ap9

Christina Lake Cannabis Closes First Tranche of Non-Brokered Private Placement

3 hours from now
Nxera Pharma’s Partner Neurocrine Biosciences Initiates Phase 3 Registrational Program of NBI-1117568 as a Potential Treatment for Adults with Schizophrenia

3 hours from now
Postal Realty Trust, Inc. Reports First Quarter 2025 Results

3 hours from now
Dimerix and Amicus Therapeutics Announce Exclusive License Agreement for DMX-200 in the United States

3 hours from now
Nxera Pharma Appoints Top-Ranked Biopharma Investment Analyst Shinya Tsuzuki as Head of Investor Relations

2 hours from now